U.S. flag

An official website of the United States government

NM_005957.5(MTHFR):c.1129C>T (p.Arg377Cys) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Jan 1, 2022
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000756357.27

Allele description [Variation Report for NM_005957.5(MTHFR):c.1129C>T (p.Arg377Cys)]

NM_005957.5(MTHFR):c.1129C>T (p.Arg377Cys)

Gene:
MTHFR:methylenetetrahydrofolate reductase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.22
Genomic location:
Preferred name:
NM_005957.5(MTHFR):c.1129C>T (p.Arg377Cys)
HGVS:
  • NC_000001.11:g.11794766G>A
  • NG_013351.1:g.16338C>T
  • NM_001330358.2:c.1252C>T
  • NM_005957.5:c.1129C>TMANE SELECT
  • NP_001317287.1:p.Arg418Cys
  • NP_005948.3:p.Arg377Cys
  • NP_005948.3:p.Arg377Cys
  • LRG_726t1:c.1129C>T
  • LRG_726:g.16338C>T
  • LRG_726p1:p.Arg377Cys
  • NC_000001.10:g.11854823G>A
  • NM_005957.4:c.1129C>T
  • NM_005957.5:c.1129C>T
  • P42898:p.Arg377Cys
Protein change:
R377C; ARG377CYS
Links:
UniProtKB: P42898#VAR_009534; OMIM: 607093.0011; dbSNP: rs121434296
NCBI 1000 Genomes Browser:
rs121434296
Molecular consequence:
  • NM_001330358.2:c.1252C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005957.5:c.1129C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
2

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000884147ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process)
Uncertain significance
(Feb 6, 2018)
germlineclinical testing

Citation Link,

SCV002496458CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Pathogenic
(Jan 1, 2022)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes2not providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV000884147.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.1129C>T; p.Arg377Cys variant has been reported multiple times in the literature. An African-American/Caucasian female with lethargy and failure to thrive at one month of age, and seizures, apnea, and hypotonia at three months of age was reported to be compound heterozygous for this variant as well as p.Leu323Pro (Goyette 1996). A 13-year-old male with developmental delay was reported to be compound heterozygous for the p.Arg377Cys and p.Met338Thr variants (Sibani 2003), and a study of families diagnosed with severe MTHFR deficiency reported two further individuals heterozygous for p.Arg377Cys and either p.His181Asp or p.Cys193Tyr (Tonetti 2003). A study of an Amish community found four children homozygous for the p.Arg377Cys variant, all of whom had slow head growth and arrested development in the first few months of life; while 68 heterozygotes were among 230 healthy individuals in the community, for an estimated population carrier frequency of 30% (Strauss 2007). The four p.Arg377Cys homozygotes all displayed elevated plasma N-homocysteinylated protein, Hcy-thiolactone and total homocysteine concentrations (Jakubowski 2008). This variant is listed in the genome Aggregation Database (gnomAD) with an overall population frequency of 0.004% (identified on 5 out of 126,714 chromosomes) and an East Asian population frequency of zero (out of 18,870 chromosomes), while the Exome Sequencing Project reports the variant frequency as 0.008% (identified on 1 out of 13,005 chromosomes). However, a study of congenital heart disease risk in China identified the p.Arg377Cys variant in a homozygous state in 12 healthy individuals and 27 affected patients among 467 studied Chinese Han individuals, with an allele frequency of over 25% (Zhang 2014). The discrepancy between this report and those of the population databases has not yet been explained. Although these findings are suggestive, based on the available evidence, the clinical significance of the p.Arg377Cys variant cannot be determined with certainty.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV002496458.16

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided2not providednot providednot provided

Last Updated: Sep 16, 2024